1. Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial. Issue 3 (14th March 2022) Authors: Schietzel, Simeon; Bally, Lia; Cereghetti, Grazia; Faller, Nicolas; Moor, Matthias B; Vogt, Bruno; Rintelen, Felix; Trelle, S; Fuster, Daniel Journal: BMJ open Issue: Volume 12:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗